RI
RTW Investments Portfolio holdings
AUM
$7.02B
This Quarter Return
+23.76%
1 Year Return
+28.16%
3 Year Return
+245.48%
5 Year Return
+425.65%
10 Year Return
+5,642.23%
AUM
$4.34B
AUM Growth
+$4.34B
(+12%)
Cap. Flow
-$78.5M
Cap. Flow
% of AUM
-1.81%
Top 10 Holdings %
Top 10 Hldgs %
48.91%
Holding
111
New
4
Increased
17
Reduced
21
Closed
25
Top Buys
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$65M |
| 2 |
Ultragenyx Pharmaceutical
RARE
|
$40.9M |
| 3 |
PTC Therapeutics
PTCT
|
$28.9M |
| 4 |
Immunocore
IMCR
|
$21.4M |
| 5 |
Masimo
MASI
|
$12.6M |
Top Sells
| 1 |
Quanterix
QTRX
|
$29.5M |
| 2 |
Tandem Diabetes Care
TNDM
|
$28.7M |
| 3 |
Veru
VERU
|
$25.1M |
| 4 |
Globus Medical
GMED
|
$22.3M |
| 5 |
AXNX
Axonics, Inc. Common Stock
AXNX
|
$20.8M |
Sector Composition
| 1 | Healthcare | 99.21% |
| 2 | Financials | 0.67% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Ventyx Biosciences
VTYX
$171M
| $54.2M | 1.25% | 1,551,778 | – | – |
|
27
PMV Pharmaceuticals
PMVP
$74.2M
| $51.8M | 1.2% | 4,356,920 -38,757 | -0.9% | -$461K |
|
28
Regenxbio
RGNX
$451M
| $48.8M | 1.12% | 1,845,366 | – | – |
|
29
Stoke Therapeutics
STOK
$1.08B
| $46.9M | 1.08% | 3,651,823 | – | – |
|
|
CINC
30
DELISTED
CinCor Pharma, Inc. Common Stock
CINC
| $45.6M | 1.05% | 1,389,705 | – | – |
|
|
31
Globus Medical
GMED
$8.27B
| $44.5M | 1.03% | 747,685 -373,842 | -33% | -$22.3M |
|
32
Milestone Pharmaceuticals
MIST
$156M
| $39.7M | 0.91% | 4,315,102 | – | – |
|
33
Guardant Health
GH
$8.41B
| $39.1M | 0.9% | 725,887 -199,000 | -22% | -$10.7M |
|
34
Protagonist Therapeutics
PTGX
$3.67B
| $35.2M | 0.81% | 4,176,837 -617,662 | -13% | -$5.21M |
|
35
Tarsus Pharmaceuticals
TARS
$2.47B
| $34.6M | 0.8% | 2,023,179 +9,578 | +0.5% | +$164K |
|
36
Fulcrum Therapeutics
FULC
$351M
| $32.2M | 0.74% | 3,985,910 +24,716 | +0.6% | +$200K |
|
|
BCYC
37
Bicycle Therapeutics
BCYC
$511M
| $29.7M | 0.68% | 1,276,276 | – | – |
|
|
AVDL
38
Avadel Pharmaceuticals
AVDL
$1.43B
| $28.8M | 0.66% | 5,741,939 | – | – |
|
39
GH Research
GHRS
$837M
| $25.2M | 0.58% | 2,168,957 | – | – |
|
40
C4 Therapeutics
CCCC
$185M
| $24.7M | 0.57% | 2,819,472 -275,353 | -9% | -$2.41M |
|
41
10x Genomics
TXG
$1.74B
| $18.2M | 0.42% | 639,654 -319,827 | -33% | -$9.11M |
|
|
TSVT
42
DELISTED
2seventy bio
TSVT
| $17.9M | 0.41% | 1,229,508 | – | – |
|
|
43
Tandem Diabetes Care
TNDM
$845M
| $15.4M | 0.36% | 322,000 -600,630 | -65% | -$28.7M |
|
44
Apyx Medical
APYX
$75.3M
| $15.3M | 0.35% | 3,398,279 | – | – |
|
45
Outset Medical
OM
$247M
| $14.5M | 0.33% | 909,652 | – | – |
|
46
Castle Biosciences
CSTL
$696M
| $13.5M | 0.31% | 516,995 -396,794 | -43% | -$10.3M |
|
|
DMTK
47
DELISTED
DermTech, Inc. Common Stock
DMTK
| $12.4M | 0.28% | 3,118,666 | – | – |
|
|
JNCE
48
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $11.9M | 0.28% | 5,106,341 +747,908 | +17% | +$1.75M |
|
|
OLK
49
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
| $11.9M | 0.27% | 981,918 -580,304 | -37% | -$7.04M |
|
|
THRD
50
DELISTED
Third Harmonic Bio
THRD
| $11.6M | 0.27% | +609,687 | New | +$11.6M |
|